Doctors at Qatar’s first specialist women’s and children’s hospital Sidra Medicine have successfully separated conjoined twins, marking a first for the country. The surgery establishes an alternative for patients who previously had limited choices for the successful treatment and care of complex pediatric diseases in the region.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8422651-conjoined-twins-find-new-lease-on-life/
Building on the results of the largest behaviour change study on physical activity, Vitality and its global network of insurers have collectively committed to improving the health of millions over the next seven years. This is in line with the World Health Organizations’ Global Action Plan on Physical Activity, which aims to address the dramatic growth in lifestyle diseases, caused in part by a lack of exercise.
Incentives and Physical Activity, conducted by leading independent research institute, RAND Europe, found an average 34% increase in activity levels of participants using Vitality Active Rewards with Apple Watch. The study examined the behaviours of over 400 000 people in the UK, US and South Africa.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8458751-vitality-insurers-people-more-active-2025/
The CVS Caremark Charitable Trust, a private foundation created by CVS Caremark Corporation (NYSE: CVS) today announced the recipients of the “Innovations in Community Health” grants, which have been awarded to community health centers nationwide through a partnership with the National Association of Community Health Centers (NACHC). The grants will help community health centers increase access to quality health care and produce better health outcomes while reducing costs for patients and healthcare systems.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61405-cvs-caremark-charitable-trust-awards-21-innovations-in-community-health
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
As part of their ongoing partnership to help Americans improve their health and curb the onset of chronic diseases like diabetes, CVS/pharmacy and the 50 Million Pound Challenge announced today the availability of the 32-page 50 Million Pound Challenge Guide in all CVS/pharmacy retail locations.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/43523/
A study published in the Journal of Infectious Diseases indicates that treatment with oseltamivir significantly reduces mortality in patients with influenza A/H5N1, or ‘bird flu,’ even when given late in the course of illness.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/outcome/46648/
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced the opening of a state-of-the-art research center in Billerica, MA, establishing it as a “hub” within the Merck KGaA research organization. Representing a $65 million investment, the Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and infertility. Nearly 100 new jobs will be added in Massachusetts as a result of the building expansion.
To view Multimedia News Release, go to
http://multivu.prnewswire.com/mnr/emdserono/48166/
To help Americans determine their risk for chronic diseases and get them on a path to better health, CVS/pharmacy announced today the launch of the 2011 “To Your Health” program, offering free preventive health screenings at more than 800 events in communities across the country. The program will get underway in Houston on Saturday, March 5th, and continue in Dallas, Los Angeles, Washington D.C., Atlanta, Philadelphia, Chicago and Miami.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cvs/48303/
The new BUENA SALUD™ series of books (the phrase translates to “Good Health”) launches today with titles on heart health (foreword by CEO of the American College of Cardiology) and diabetes (foreword by CEO of the American Diabetes Association). Written by Dr. Jane L. Delgado, President and CEO of the National Alliance for Hispanic Health, the book series is the first ever devoted to the health experiences of a growing Hispanic readership. The guides feature real-life stories and deliver health information and cutting-edge medical advances for individual diseases and conditions in a warm and conversational tone. The books are published simultaneously in English and Spanish. These authoritative and accessible guides each feature a “10-Point Program for Health,” facts and information in a useful Q&A format, and key questions to ask health providers. In a just published feature review, the Library Journal gave a starred review and called the BUENA SALUD™ series “essential reading” and “a crucial addition to any consumer health collection.”
EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that the company’s state-of-the-art research center in Billerica, MA, is LEED® Gold certified under the U.S. Green Building Council and verified by the Green Building Certification Institute (GBCI). LEED® is the nation’s preeminent program for the design, construction and operation of high performance green buildings. The Billerica research facility supports the company’s commitment to developing and discovering innovative treatments in oncology, neurodegenerative diseases and fertility, and is one of only five laboratories in Massachusetts to achieve this high rating.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/emdserono/49715/
Chlamydia. HPV. Herpes. Gonorrhea. They’re not easy topics to bring up with your teen, but sexually transmitted disease (STD) rates are rising among adolescents. Nearly half of all new STD cases are in young people between the ages of 15 and 24, according to the Centers for Disease Control and Prevention (CDC).
Parents can help slow the rise in STD rates by talking to teens about STDs, STD prevention and the importance of STD testing — but first they need to have the facts. BeSmartBeWell.com prepares parents to talk to their kids about STDs by offering a variety of expert interviews, life story videos and resources. Watch the video What Can I Do About It?
To view Multimedia News Release, go to http://www.multivu.com/mnr/50823-bsbw-sexually-transmitted-diseases-std-teens-what-parents-need-to-know
On October 21st, 2011, Lancôme invites customers to experience the “Beauty of Giving” by celebrating Genes Day, a one-day national event Lancôme began in 2010 to support St. Jude Children’s Research Hospital, one of the world’s premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases. On this day, Lancôme will donate $7 from the sale of every bottle of Génifique Youth Activating Concentrate to St. Jude. (This is in addition to special promotions and events nationwide surrounding Genes Day throughout the month of October.)
To view Multimedia News Release, go to http://www.multivu.com/mnr/52300-lancome-genes-day-2011-st-jude-julia-roberts-genifique-beauty-of-giving
